2m 2m 2m 2m 2m 2m 2m
Macrogenics (MGNX)
NASDAQ
$4.01+$0.010 (+0.25%)
Price as of Sep 11, 2026 7:30 PM EDT- $254.8MMarket Cap
- 151.57%1-Year Change
- BiotechnologyIndustry
Macrogenics (MGNX)
$4.01+$0.010 (+0.25%)
MGNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.00 | ||
Change | +$0.03 (+0.76%) | ||
Open | $4.02 | ||
High | $4.09 | ||
Low | $3.91 | ||
Previous Close | $3.97 | ||
Volume | 381,932 | ||
30-Day Average Volume | 500,451 | ||
1-Week Change | -9.09% | ||
1-Month Change | 2.04% | ||
1-Year Change | 151.57% | ||
3-Year Change | -26.20% | ||
5-Year Change | -84.06% | ||
Fundamentals | |||
Shares Outstanding | 63.7M | ||
Total Assets | $345.4M | ||
Market Cap | $254.8M | ||
Enterprise Value | $140.9M | ||
Period: QTR TTM FY | |||
Revenue | $25.5M | ||
Net Income | $19.5M | ||
Free Cash Flow | -$41.6M | ||
EBIT | $23.9M | ||
EBITDA | $24.6M | ||
Net Working Capital | $212.9M | ||
EPS | $0.31 | ||
Enterprise Value/EBITDA | 6 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 6 | ||
P/E | 13 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue